摘要 |
<p>The present invention provides a herpes simplex virus strain having a functional ICP27 gene and lacking at least a functional ICP4 gene and a functional ICP34.5 gene. It also provides the use of a herpes simplex virus strain which lacks at least a functional ICP4 gene and a functional ICP34.5 gene in the treatment of disorders of, or injuries to, the nervous system of a mammal.</p> |